Multiple System Atrophy Research
Multiple system atrophy affects movement, balance and the body’s automatic functions. Here is an overview of the condition and of what stem cell research is currently exploring.
- Neurological
- 2 min
06/24/2026
Understanding MSA
Multiple system atrophy, often shortened to MSA, is a rare progressive neurological disorder. It affects movement and balance, and it also disrupts the autonomic nervous system, which controls functions people rarely think about, such as blood pressure, bladder control and digestion. Because so many systems are involved, symptoms overlap and care can be complex.
People with MSA are often cared for by several specialists at once, and families play a large part in daily support. That makes clear, shared information especially important.
Why Researchers Are Looking at Cells
Current care for MSA focuses on managing symptoms. Researchers continue to test new approaches, and regenerative medicine is one area under study. Mesenchymal stem cells interest scientists because they release signals that may influence inflammation and support the environment around nerve cells. Studies are exploring whether this could affect the course of the disease, and findings remain preliminary.
Reading the Research
Patients and families looking into stem cell treatment for MSA usually want a clear picture of what is known. A few points help:
- Studies in MSA are relatively few, because the condition is rare.
- Early results cannot be applied to every patient.
- Each new study adds detail, and conclusions may change.
Talking It Through
A neurologist who knows the patient’s history is the best partner for weighing new options.
At Regeneration Clinic Panama, we use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. A medical evaluation decides whether treatment is appropriate, and results vary between patients. Our team explains what is known and what is not before any decision is made.
06/24/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






